Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	11.13
Bid (Size)	11.20 (11)
Ask (Size)	11.21 (1)
Prev. Close	11.13
Today's Range	11.13 - 11.13
52wk Range	2.865 - 11.40
Shares Outstanding	61,930,485
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Verve Therapeutics Inc (NASDAQ:VERV): A High-Growth Momentum Stock Aligned with Minervini’s Trend Model

August 02, 2025

Verve Therapeutics (VERV) aligns with Minervini’s trend model, showing strong technicals, 93% 3-month growth, and 479% revenue surge—ideal for high-growth investors.

Via Chartmill

Performance

YTD	+85.2%	+85.2%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+102.4%	+102.4%
1 Year	+92.2%	+92.2%

More News

3 Bullish Biotech Stocks With Explosive Growth Trends

July 21, 2025

Via MarketBeat

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook

July 15, 2025

Via MarketBeat

VERVE THERAPEUTICS INC (NASDAQ:VERV) - A High-Growth Biotech Stock Meeting Minervini's Criteria

July 09, 2025

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

June 27, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

June 20, 2025

Via The Motley Fool

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

June 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV

June 18, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst

June 18, 2025

Via Benzinga

This Verve Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

June 18, 2025

Via Benzinga

Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)

June 18, 2025

Via Chartmill

5 Analysts Assess Verve Therapeutics: What You Need To Know

June 17, 2025

Via Benzinga

These stocks are moving in today's session

June 17, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

June 17, 2025

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 17, 2025

Via Benzinga

Which stocks are moving on Tuesday?

June 17, 2025

Via Chartmill

June 17, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

June 17, 2025

From Halper Sadeh LLC

Via Business Wire

Why Verve Therapeutics Stock Is Skyrocketing Today

June 17, 2025

Via The Motley Fool

Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday

June 17, 2025

Via Benzinga

Which stocks are gapping on Tuesday?

June 17, 2025

Via Chartmill

Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside

June 17, 2025

Via AB Newswire

Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’

June 17, 2025

Via Stocktwits

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

June 17, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Verve Therapeutics, Inc. - Common Stock publicly traded?

Yes, Verve Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Verve Therapeutics, Inc. - Common Stock trade on?

Verve Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Verve Therapeutics, Inc. - Common Stock?

The ticker symbol for Verve Therapeutics, Inc. - Common Stock is VERV on the Nasdaq Stock Market

What is the current price of Verve Therapeutics, Inc. - Common Stock?

The current price of Verve Therapeutics, Inc. - Common Stock is 11.13

When was Verve Therapeutics, Inc. - Common Stock last traded?

The last trade of Verve Therapeutics, Inc. - Common Stock was at 07/24/25 04:00 PM ET

What is the market capitalization of Verve Therapeutics, Inc. - Common Stock?

The market capitalization of Verve Therapeutics, Inc. - Common Stock is 689.29M

How many shares of Verve Therapeutics, Inc. - Common Stock are outstanding?

Verve Therapeutics, Inc. - Common Stock has 689M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.